physIQ Heart Rhythm and Respiratory Module vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

physIQ Heart Rhythm and Respiratory Module

by physIQ

EchoNext

by Pathway Labs

AI Verdict

While both tools are FDA-cleared cardiology AI solutions, they address different aspects of cardiac health monitoring and diagnosis. physIQ's tool focuses on continuous, real-time physiological monitoring using wearable biosensors to detect subtle changes and early signs of decompensation, whereas EchoNext analyzes standard ECGs to detect hidden structural heart diseases. Therefore, physIQ is better suited for continuous patient monitoring and early detection of physiological decline, while EchoNext excels in diagnostic support for identifying underlying structural heart conditions.

Choose physIQ Heart Rhythm and Respiratory Module if…

Choose physIQ Heart Rhythm and Respiratory Module if you require continuous, long-term remote physiological monitoring of patients using wearable biosensor data. This tool excels at establishing a personalized physiological baseline for each patient and detecting subtle deviations and early signs of decompensation in heart rhythm and respiration over time, making it ideal for managing chronic conditions or post-acute care.

View physIQ Heart Rhythm and Respiratory Module →

Choose EchoNext if…

Choose EchoNext if you need an FDA-cleared AI tool to analyze standard 12-lead ECGs for the detection of hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension. This tool is best suited for broad screening in clinical settings, from major hospitals to community practices, to identify patients who may require further cardiac evaluation.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	physIQ Heart Rhythm and Respiratory Module	EchoNext
Pricing	Contact for pricing	Starts at $600/month
Deployment	Cloud-based platform	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Without direct user experience data or detailed interface descriptions for either tool, it's difficult to definitively pick a winner. Both tools are designed for use by medical professionals and integrate into clinical workflows, suggesting a focus on usability within their respective contexts. physIQ focuses on continuous, passive data collection and analytics, likely centered on dashboard interpretation of alerts and trends. EchoNext is available through the OpenEvidence clinical decision support platform, implying an integration into existing physician workflows.

Clinical Value

physIQ Heart Rhythm and Respiratory Module

While both are FDA-cleared and offer significant clinical utility, physIQ's continuous, personalized physiological monitoring from wearable biosensor data allows for the detection of subtle physiological changes and early signs of decompensation across both cardiac and respiratory functions. This proactive, predictive insight for long-term patient management offers a broader and potentially more impactful clinical value compared to EchoNext's diagnostic screening for structural heart disease from ECGs.

Pricing & Value

EchoNext

EchoNext offers transparent tiered pricing starting at $600/month, with details on different plans and potential discounts. In contrast, physIQ only states 'contact for pricing,' which provides no public indication of cost and suggests a less transparent, likely enterprise-level sales process. This transparency gives EchoNext an edge in this dimension, allowing potential users to better understand the financial commitment upfront.

Enterprise Readiness

physIQ Heart Rhythm and Respiratory Module

PhysIQ explicitly states it is an 'industry-leading, enterprise-ready cloud platform' and directly claims HIPAA compliance and the availability of a Business Associate Agreement (BAA). EchoNext is available through a clinical decision support platform and is designed for broad access, but its enterprise-grade compliance strategy isn't as explicitly detailed as physIQ's.

Innovation

physIQ Heart Rhythm and Respiratory Module

PhysIQ stands out for its innovation with AI-based personalized physiology analytics that learn individual patient baselines from continuous wearable biosensor data to detect subtle changes and early signs of decompensation. This represents a pioneering approach in digital medicine, focusing on predictive insights. EchoNext, while innovative in its ability to detect hidden structural heart disease from standard ECGs, primarily optimizes existing diagnostic workflows rather than introducing a fundamentally new paradigm in patient monitoring.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer specific details about the level of support or documentation available for either physIQ Heart Rhythm and Respiratory Module or EchoNext. Therefore, it is not possible to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	physIQ Heart Rhythm and Respiratory Module	EchoNext
Name	physIQ Heart Rhythm and Respiratory Module	EchoNext
Company	physIQ	Pathway Labs
Tagline	The leader in digital medicine, dedicated to generating unprecedented health insight using continuous wearable biosensor data and advanced analytics.	How's your heart?
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, Clinical Decision Support & Reference, Lab & Diagnostics
Specialties	Cardiology, Critical Care, Pulmonology	Cardiology, Family Medicine, Hospital Medicine, Internal Medicine
Key Features	AI-based personalized physiology analytics, Continuous wearable biosensor data collection, FDA-cleared analytics and digital biomarkers, Learns individual patient baseline, Detects subtle physiological changes and early signs of decompensation, Calculates heart rate and heart rate variability, Detects atrial fibrillation, Determines respiration rate	AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support

Videos

Demos, reviews, and walkthroughs featuring physIQ Heart Rhythm and Respiratory Module and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows, and what is the expected learning curve for physicians?

physIQ Heart Rhythm and Respiratory Module is designed to be integrated by the customer organization into an end-to-end system, from biosensor data collection to clinician display, suggesting a need for custom integration work. It focuses on continuous remote patient monitoring. EchoNext, on the other hand, is available through the OpenEvidence clinical decision support platform and analyzes standard 12-lead ECGs, which are routinely collected, potentially streamlining its integration into existing diagnostic pathways. The learning curve for physIQ may involve understanding continuous data streams and personalized baselines, while EchoNext's learning curve would likely focus on interpreting its AI-powered insights for structural heart disease detection from standard ECGs.

What is the depth of EHR integration for each tool, and how does it support a comprehensive patient view?

physIQ is designed to integrate with existing electronic health record (EHR) systems, providing healthcare professionals with a comprehensive view of a patient's health status by analyzing biometrics, wearables, and medical records. EchoNext is available through the OpenEvidence clinical decision support platform, implying integration within that platform, but specific details on its direct EHR integration capabilities for a comprehensive patient view are not provided. Both tools aim to enhance care delivery by leveraging AI and providing insights to healthcare providers.

What are the accuracy and sensitivity metrics for each tool, particularly in their respective clinical applications?

physIQ's analytics are FDA-cleared and detect subtle physiological changes and early signs of decompensation, calculating heart rate, heart rate variability, and detecting atrial fibrillation using ambulatory ECG data. EchoNext has demonstrated high accuracy in detecting hidden structural heart disease, achieving an AUROC of 85% in internal tests and 78-80% in external validation. In a study, EchoNext showed higher accuracy (77%) compared to cardiologists at baseline (64%) for ECG interpretations.

Given their specialized focus, what clinical contexts are each tool best suited for, and are there any overlapping or complementary uses?

physIQ Heart Rhythm and Respiratory Module is best suited for continuous remote patient monitoring in subacute clinical and non-clinical settings, focusing on early detection of physiological changes and atrial fibrillation using wearable biosensor data. EchoNext is designed for broad access, from major hospitals to community practices, and is ideal for screening for hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, using standard 12-lead ECGs. While physIQ monitors ongoing cardiac rhythm and respiratory changes, EchoNext provides a diagnostic aid for structural heart issues from a single ECG, making them complementary in a comprehensive cardiology practice.

What kind of customer support and training can physicians expect for each tool, and how does this impact the time-to-value?

The provided information does not detail specific customer support or training programs for either physIQ or EchoNext. However, physIQ is intended to be integrated by the customer organization, which might imply a need for internal expertise or third-party support during implementation. EchoNext's availability through the OpenEvidence platform might suggest support is handled through that platform. The time-to-value for both would depend on the ease of integration, the effectiveness of any provided training, and the immediate clinical utility experienced by the physician.

Beyond HIPAA, what additional security features or protocols do these tools employ to protect patient data?

The provided information explicitly states both tools are HIPAA compliant and have BAA availability. However, it does not detail any additional security features or protocols beyond HIPAA for either physIQ or EchoNext. Further inquiry would be needed to understand their specific security postures beyond the baseline HIPAA compliance.

Are there any customer references or case studies available that highlight the real-world performance and physician experience with these tools, especially concerning multi-site rollouts or audit-trail features?

The provided information does not explicitly mention the availability of customer references or case studies for either physIQ or EchoNext. However, EchoNext has undergone prospective trials and silent deployments, with findings highlighting its impact on diagnosing structural heart disease and identifying gaps in clinical care. It is also part of a large cardiovascular AI randomized controlled trial. While audit-trail features are crucial for understanding clinical workflow and EHR interactions, the provided descriptions do not detail specific audit-trail functionalities for either tool.